National Comprehensive Cancer Network



About NCCN

Prostate Cancer Early Detection Panel - Disclosures as of 9/3/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Gerald Andriole, MD

None

None

Bayer HealthCare;
Genomic Health, Inc.;
GlaxoSmithKline;
Myriad Genetic Laboratories, Inc.;
Augmenix;
Medivation

None

None

9/8/2014

Robert R. Bahnson, MD

None

Various Law Firms

None

None

None

6/16/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

Peter R. Carroll, MD, MPH

Genomic Health, Inc.;
Myriad Genetic Laboratories, Inc.;
National Cancer Institute;
Department of Defense

Medivation/Astellas

None

None

None

10/27/2014

Erik P. Castle, MD

None

None

None

None

None

10/3/2014

William J. Catalona, MD

Beckman-Coulter, Incorporated;
deCODE genetics, Inc;
Ohmx

Beckman Coulter Inc;
deCODE genetics;
Ohmx

Beckman-Coulter, Inc;
Ohmx, Inc

Ohmx Inc

None

5/27/2014

Douglas M. Dahl, MD

None

None

None

None

None

8/24/2014

John W. Davis, MD

Jannsen Pharmaceutica Products, LP;
Janssen Pharmaceutica Products;
Myriad Genetic Laboratories, Inc.;
Genome DX;
Genprobe;
Mimedx

Astellas/Medivation

Springer U.S.

None

None

8/26/2015

Jonathan I. Epstein, MD

None

None

aperio;
dianon;
metamark genetics

None

None

8/10/2015

Ruth B. Etzioni, PhD

None

None

None

None

None

8/19/2014

Thomas A. Farrington, BSEE

None

None

None

None

None

6/15/2015

Deborah Freedman-Cass, PhD

None

None

None

None

None

4/9/2015

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

George P. Hemstreet, III, MD, PhD

None

None

None

None

None

8/22/2014

Mark H. Kawachi, MD

None

None

None

None

None

8/28/2015

Simon Kim, MD, MPH

         

Pending

Paul H. Lange, MD

None

None

None

None

None

8/13/2015

Kevin R. Loughlin, MD

None

None

None

None

None

9/4/2014

William Lowrance, MD, MPH

Myriad Genetic Laboratories, Inc.;
National Cancer Institute;
Argos Therapeutics;
GenomeDx

MDxHealth

None

None

None

11/5/2014

Paul Maroni, MD

None

None

None

None

None

8/7/2015

Joan S. McClure, MS

None

None

None

None

None

6/18/2015

James L. Mohler, MD

National Cancer Institute

Genomic Health, Inc.

None

Androbiosys, Inc.

None

8/18/2015

Todd M. Morgan, MD

Myriad Genetic Laboratories, Inc.;
MDxHealth

Myriad Genetic Laboratories, Inc.;
MDxHealth

None

None

None

8/6/2015

Kelvin A. Moses, MD, PhD

None

Nutech Biomarkers

None

None

None

6/19/2015

Robert B. Nadler, MD

None

None

None

None

None

7/14/2014

J. Kellogg Parsons, MD, MHS

National Cancer Institute;
Watson Pharmaceuticals, Inc.

Legal firms

None

None

None

7/31/2014

Michael Poch, MD

None

None

None

None

None

10/28/2014

Chuck Scales, MD

None

None

None

None

None

1/24/2014

Terrence M. Shaneyfelt, MD, MPH

None

None

None

None

None

8/13/2015

Dorothy Shead, MS

None

None

None

None

None

6/22/2015

Marc C. Smaldone, MD, MSHP

None

None

None

None

None

9/4/2014

Geoffrey Sonn, MD

None

None

None

None

None

8/7/2015

Preston C. Sprenkle, MD

None

None

None

None

None

9/17/2014

Andrew J. Vickers, PhD

National Cancer Institute

COONEY, SCULLY AND DOWLING;
Opko diagnostics

GenomeDX

Arctic Partners;
OPKO

None

8/17/2015

Robert Wake, MD

None

None

None

None

None

8/26/2014